Reconstitution of thymic function after stem cell transplantation in humans

Current Opinion in Hematology

Volumn 9, Issue 6, 2002, Pages 490-496

  Hakim, Frances T ^a   Gress, Ronald E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR;

HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THYMOCYTE; THYMUS FUNCTION; CYTOLOGY; GRAFT SURVIVAL; GROWTH, DEVELOPMENT AND AGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE SYSTEM; PHYSIOLOGY; THYMUS;

GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0036838265     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200211000-00004     Document Type: Review

References (58)

1. Schlenke P, Sheikhzadeh S, Weber K, et al.: Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001, 28:251-257.
2. Mackall CL, Stein D, Fleisher TA, et al.: Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 2000, 96:754-762.
3. Nordoy T, Kolstad A, Endresen P, et al.: Persistent changes in the immune system 4-10 years after ABMT. Bone Marrow Transplant 1999, 24:873-878.
4. Storek J, Joseph A, Espino G, et al.: Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001, 98:3505-3512.
5. Roux E, Dumont-Girard F, Starobinski M, et al.: Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000, 96:2299-2303.
6. Hirokawa M, Horiuchi T, Kitabayashi A, et al.: Delayed recovery of CDR3 complexity of the T-cell receptor-beta chain in recipients of allogeneic bone marrow transplants who had virus-associated interstitial pneumonia: monitor of T-cell function by CDR3 spectratyping. J Allergy Clin Immunol 2000, 106:S32-S39.
7. Nordoy T, Husebekk A, Aaberge IS, et al.: Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT: serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant 2001, 28:681-687.
8. Hakim FT, Cepeda R, Kaimei S, et al.: Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997, 90:3789-3798.
9. Mackall CL, Hakim FT, Gress RE: T-cell regeneration: all repertoires are not created equal. Immunol Today 1997, 18:245-251.
10. Mackall CL, Granger L, Sheard MA, et al.: T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993, 82:2585-2594.
11. Mackall CL, Fleisher TA, Brown MR, et al.: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994, 84:2221-2228.
12. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
13. De Rosa SC, Herzenberg LA, Roederer M: 11-Color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001, 7:245-248.
14. +) T-cell development. Immunol Today 1999, 20:177-180.
15. Douek DC, Vescio RA, Betts MR, et al.: Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355:1875-1881.
16. Hazenberg MD, Verschuren MCM, Hamann D, et al.: T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001, 79:631-640.
17. Douek DC, Betts MR, Hill BJ, et al.: Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001, 167:6663-6668.
18. Poulin JF, Viswanathan MN, Harris JM, et al.: Direct evidence for thymic function in adult humans. J Exp Med 1999, 190:479-486.
19. Markert ML Boeck A, Hale LP, et al.: Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med 1999, 341:1180-1189.
20. Heitger A, Greinix H, Mannhalter C, et al.: Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 2000, 69:2366-2373.
21. Gorski J, Yassai M, Zhu X, et al.: Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J Immunol 1994, 152:5109-5119.
22. Dumont-Girard F, Roux E, van Lier RA, et al.: Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998, 92:4464-4471.
23. Talvensarri K, Clave E, Douay C, et al.: A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002, 99:1458-1464.
24. Fry TJ, Mackall CL: Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001, 22:564-571.
25. Ernst B, Lee DS, Chang JM, et al.: The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999, 11:173-181.
26. Tan JT, Dudl E, LeRoy E, et al.: IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001, 98:8732-8737.
27. Bolotin E, Annett G, Parkman R, et al.: Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999, 23:783-788.
28. Fry TJ, Connick E, Falloon J, et al.: A potential role for interleukin-7 in T-cell homeostasis. Blood 2001, 97:2983-2990.
29. Rutella S, Pierelli L, Bonanno G, et al.: Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol 2001, 29:1503-1516.
30. Kumaki S, Minegishi M, Fujie H, et al.: Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. Int J Hematol 1998, 67:307-312.
31. Hazenberg MD, Otto SA, de Pauw ES, et al.: T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002, 99:3449-3453.
32. -) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire. Bone Marrow Transplant 2001, 27:731-739.
33. Kern F, Khatamzas E, Surel I, et al.: Distribution of human CMV-specific memory T cells among the CD8pos subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999, 29:2908-2915.
34. Mackall CL, Bare CV, Granger LA, et al.: Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996, 156:4609-4616.
35. Klein AK, Patel DD, Gooding ME, et al.: T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001, 7:454-466.
36. Verfuerth S, Peggs K, Vyas P, et al.: Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood 2000, 95:3990-3995.
37. Margolis DA, Casper JT, Segura AD, et al.: Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant 2000, 6:408-415.
38. Lin MT, Tseng LH, Frangoul H, et al.: Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood 2000, 95:3832-3839.
39. Haynes BF, Markert ML, Sempowski GD, et al.: The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 2000, 18:529-560.
40. Jamieson BD, Douek DC, Killian S, et al.: Generation of functional thymocytes in the human adult. Immunity 1999, 10:569-575.
41. Steffens CM, Al-Harthi L, Shott S, et al.: Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 2000, 97:95-101.
42. + T cell clones in elderly humans. J Immunol 1997, 158:4493-4499.
43. Weinberg K, Blazar BR, Wagner JE, et al.: Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001, 97:1458-1466.
44. Hochberg EP, Chillemi AC, Wu CJ, et al.: Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 2001, 98:1116-1121.
45. Mariani S, Coscia M, Even J, et al.: Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. Br J Haematol 2001, 113:1051-1059.
46. Hara M, McAdams HP, Vredenburgh JJ, et al.: Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer. AJR Am J Roentgenol 1999, 173:1341-1344.
47. Godthelp BC, van Tol MJD, Vossen JM, et al.: T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires. Blood 1999, 94:4358-4369.
48. Orsini E, Alyea EP, Schlossman R, et al.: Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplant 2000, 25:623-632.
49. Desbarats J, Lapp WS: Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med 1993, 178:805-814.
50. Ghayur T, Seemayer TA, Xenocostas A, et al.: Complete sequential regeneration of graft-vs.- host-induced severely dysplastic thymuses: implications for the pathogenesis of chronic graft- vs.-host disease. Am J Pathol 1988, 133:39-46.
51. Ribeiro RM, Mohri H, Ho DD, et al.: Modeling deuterated glucose labeling of T-lymphocytes. Bull Math Biol 2002, 64:385-405.
52. Mackall CL, Fry TJ, Bare C, et al.: IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001, 97:1491-1497.
53. -) thymocyte population. Cell Immunol 2001, 212:150-157.
54. Okamoto Y, Douek DC, McFarland RD, et al.: Effects of exogenous interleukin-7 on human thymus function. Blood 2002, 99:2851-2858.
55. Chung B, Barbara-Burnham L, Barsky L, et al.: Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 2001, 98:1601-1606.
56. Min D, Taylor PA, Panoskaltsis-Mortari A, et al.: Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002, 99:4592-4600.
57. Alpdogan O, Schmaltz C, Muriglan SJ, et al.: Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001, 98:2256-2265.
58. Fry TJ, Christensen BL, Komschlies KL, et al.: Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 2001, 97:1525-1533.